chartexchange

DMAC
DiaMedica Therapeutics Inc. Common Stock
stockNASDAQ

At CloseNov 18, 2026 3:59:43 PM EST
8.59USD+2.506%(+0.21)207,419
After-hoursNov 18, 2026 4:26:30 PM EST
8.59USD0.000%(-0.00)
Loading…
Loading…
461.88M
Healthcare
Biotechnology
HQ
Minneapolis, MN, USA
Previous Close
$8.38
Beta
1.80
52-Week High
$11.00 2026-11-04
52-Week Low
$5.25 2026-06-11
SMA 50
$8.31
SMA 200
$7.18
Avg. Vol 10D
206,914
Avg. Vol 30D
220,896
Avg. Vol 90D
191,620
Relative Vol
0.94
25.33M
0.6200%
1,452
DMAC Profile

diamedica therapeutics is a clinical-stage biopharmaceutical company that is developing innovative treatments where there is significant unmet clinical need or where no current therapies are available with the focus on neurological and kidney diseases. for more information please visit www.diamedica.com.

DMAC Performance
PeriodPriceDateChangeBeta
1W9.332026-11-12-8.25%2.155
1M7.872026-10-19+8.77%3.039
3M6.812026-08-19+25.70%2.699
6M5.572026-05-19+53.68%1.937
1Y7.302025-11-19+17.26%1.796
2Y4.042024-11-19+111.88%—
5Y3.822021-11-19+124.08%0.945
DMAC Stock Summary

DiaMedica Therapeutics Inc. Common Stock (NASDAQ:DMAC) stock price today is $8.56, and today's volume is 207,419. DMAC is up 2.148% today. The 30 day average volume is 220,896. DMAC market cap is $461.88M with 53.96M shares outstanding.